메뉴 건너뛰기




Volumn 33, Issue 2, 2012, Pages 463-474

Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site

Author keywords

CA 125; CA 19.9; Cancer of unknown primary site; CEA; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; GAMMA GLUTAMYLTRANSFERASE; GLYCOPROTEIN; NEURON SPECIFIC ENOLASE; PROSTATE SPECIFIC ANTIGEN; TAG 72 ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; TUMOR ANTIGEN;

EID: 84860290998     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0275-1     Document Type: Article
Times cited : (54)

References (47)
  • 1
    • 0034999148 scopus 로고    scopus 로고
    • The burden of illness of cancer: Economic cost and quality of life
    • Brown ML, Lipscomb J, Zinder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001;22:91-113.
    • (2001) Annu Rev Public Health. , vol.22 , pp. 91-113
    • Brown, M.L.1    Lipscomb, J.2    Zinder, C.3
  • 3
    • 33846956479 scopus 로고    scopus 로고
    • The forest and the trees: The human costs of cancer
    • Kessler LG, Ramsey SD. The forest and the trees: the human costs of cancer. J Natl Canc Inst. 2007;99:2-3.
    • (2007) J Natl Canc Inst. , vol.99 , pp. 2-3
    • Kessler, L.G.1    Ramsey, S.D.2
  • 4
    • 33748133711 scopus 로고    scopus 로고
    • Cancer of unknown primary site
    • De Vita VT, editor. 7th ed. Philadelphia: Lippincott, Williams & Wilkins
    • Greco FA, Hainsworth JD. Cancer of unknown primary site. In: de Vita VT, editor. Cancer principles and practice of oncology. 7th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 2213-36.
    • (2005) Cancer principles and practice of oncology , pp. 2213-2236
    • Greco, F.A.1    Hainsworth, J.D.2
  • 5
    • 16244396701 scopus 로고    scopus 로고
    • The value of postmortem examination in cases of metastases of unknown origin -20 years retrospective data from a tertiary care center
    • Al-Brahim N, Ross C, Carter B, Chorneyko K. The value of postmortem examination in cases of metastases of unknown origin -20 years retrospective data from a tertiary care center. Ann Diagn Pathol. 2005;9:77-80.
    • (2005) Ann Diagn Pathol. , vol.9 , pp. 77-80
    • Al-Brahim, N.1    Ross, C.2    Carter, B.3    Chorneyko, K.4
  • 6
    • 0037905503 scopus 로고    scopus 로고
    • Diagnostic and therapeutic management of cancer of an unknown primary
    • Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990-2005.
    • (2003) Eur J Cancer. , vol.39 , pp. 1990-2005
    • Pavlidis, N.1    Briasoulis, E.2    Hainsworth, J.3    Greco, F.A.4
  • 7
    • 27744523250 scopus 로고    scopus 로고
    • Tumor markers in breast cancer. European Group on Tumor Markers recommendations
    • Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M, et al. Tumor markers in breast cancer. European Group on Tumor Markers recommendations. Tumor Biol. 2005;26:281-93.
    • (2005) Tumor Biol. , vol.26 , pp. 281-293
    • Molina, R.1    Barak, V.2    Van Dalen, A.3    Duffy, M.J.4    Einarsson, R.5    Gion, M.6
  • 8
    • 34249881055 scopus 로고    scopus 로고
    • Tumour markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use
    • Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder R, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43:1348-60.
    • (2007) Eur J Cancer. , vol.43 , pp. 1348-1360
    • Duffy, M.J.1    Van Dalen, A.2    Haglund, C.3    Hansson, L.4    Holinski-Feder, R.5    Klapdor, R.6
  • 10
    • 55349134617 scopus 로고    scopus 로고
    • National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
    • Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brunner N, Chan DW, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem. 2008;54:11-79.
    • (2008) Clin Chem. , vol.54 , pp. 11-79
    • Sturgeon, C.M.1    Duffy, M.J.2    Stenman, U.H.3    Lilja, H.4    Brunner, N.5    Chan, D.W.6
  • 11
    • 36849069347 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-312.
    • (2007) J Clin Oncol. , vol.25 , pp. 5287-5312
    • Harris, L.1    Fritsche, H.2    Mennel, R.3    Norton, L.4    Ravdin, P.5    Taube, S.6
  • 13
    • 70349862783 scopus 로고    scopus 로고
    • Tumor markers in pancreatic cancer: A European Group on Tumor Markers (EGTM) status report
    • Duffy MH, Sturgeon C, Lamer R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010;21:441-7.
    • (2010) Ann Oncol. , Issue.21 , pp. 441-447
    • Duffy, M.H.1    Sturgeon, C.2    Lamer, R.3    Haglund, C.4    Holubec, V.L.5    Klapdor, R.6
  • 14
    • 33846595479 scopus 로고    scopus 로고
    • ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
    • Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24:5313-27.
    • (2006) J Clin Oncol. , Issue.24 , pp. 5313-5327
    • Locker, G.Y.1    Hamilton, S.2    Harris, J.3    Jessup, J.M.4    Kemeny, N.5    Macdonald, J.S.6
  • 15
    • 0344826667 scopus 로고    scopus 로고
    • Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer
    • Molina R, Filella X, Lejarcegui JA, Pahisa A, Torne A, Rovirosa B, et al. Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer. Tumor Biol. 2003;24:156-64.
    • (2003) Tumor Biol. , vol.24 , pp. 156-164
    • Molina, R.1    Filella, X.2    Lejarcegui, J.A.3    Pahisa, A.4    Torne, A.5    Rovirosa, B.6
  • 16
    • 0029069469 scopus 로고
    • Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients
    • Molina R, Zanon G, Filella X, Moreno F, Daniels M, Zanon G, et al. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Br Canc Res Treat. 1995;36:41-8.
    • (1995) Br Canc Res Treat. , vol.36 , pp. 41-48
    • Molina, R.1    Zanon, G.2    Filella, X.3    Moreno, F.4    Daniels, M.5    Zanon, G.6
  • 17
    • 33751534935 scopus 로고    scopus 로고
    • Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy
    • Choi S, Jang J, Lee J, Roh MH, Kim MC, Lee WS, et al. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci. 2006;51:2081-6.
    • (2006) Dig Dis Sci. , vol.51 , pp. 2081-2086
    • Choi, S.1    Jang, J.2    Lee, J.3    Roh, M.H.4    Kim, M.C.5    Lee, W.S.6
  • 19
    • 0027431788 scopus 로고
    • Incidence of pleural effusion in a well-defined region: Epidemiology study in central Bohemia
    • Maurel M, Arustova M, Stansy B, Light RW. Incidence of pleural effusion in a well-defined region: epidemiology study in central Bohemia. Chest. 1993;104:1486-9.
    • (1993) Chest. , vol.104 , pp. 1486-1489
    • Maurel, M.1    Arustova, M.2    Stansy, B.3    Light, R.W.4
  • 20
    • 0001239316 scopus 로고    scopus 로고
    • Malignant pleural and pericardial effusions
    • De Vita VT, Hellman S, Rosenberg SA, editors. 5th ed. Philadelphia: Lippincott-Raven
    • Pass HI. Malignant pleural and pericardial effusions. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; p. 2586-98.
    • Cancer Principles and Practice of Oncology , pp. 2586-2598
    • Pass, H.I.1
  • 21
    • 0002122822 scopus 로고    scopus 로고
    • Malignant ascites
    • De Vita VT, Hellman S, Rosenberg SA, editors. 5th ed. Philadelphia: Lippincott-Raven
    • Maringola FM, Schwartzentruber DJ. Malignant ascites. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; p. 2598-606.
    • Cancer Principles and Practice of Oncology , pp. 2598-2606
    • Maringola, F.M.1    Schwartzentruber, D.J.2
  • 22
    • 0037115537 scopus 로고    scopus 로고
    • Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site
    • Culine S, Kramar A, Saghatchion M, Bugat R, Lesimple T, Latholary A, et al. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol. 2002;20:4679-83.
    • (2002) J Clin Oncol. , vol.20 , pp. 4679-4683
    • Culine, S.1    Kramar, A.2    Saghatchion, M.3    Bugat, R.4    Lesimple, T.5    Latholary, A.6
  • 23
    • 1442350528 scopus 로고    scopus 로고
    • Clinical and immunohistochemical analysis of patients with unknown primary tumor. A search for prognostic factors in UPT
    • Van de Wouw AJ, Jansen RLH, Griffionen AW, Hillen HFP. Clinical and immunohistochemical analysis of patients with unknown primary tumor. A search for prognostic factors in UPT. Anticancer Res. 2004;24:297-302.
    • (2004) Anticancer Res. , vol.24 , pp. 297-302
    • Van De Wouw, A.J.1    Jansen, R.L.H.2    Griffionen, A.W.3    Hillen, H.F.P.4
  • 24
    • 57049085895 scopus 로고    scopus 로고
    • Mucins CA 125, CA 199, CA 15.3, and TAG 72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE
    • Molina R, Auge JM, Bosch X, Escudero JM, Marrades R, Vĩolas N, et al. Mucins CA 125, CA 199, CA 15.3, and TAG 72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE. Tumor Biol. 2008;29:371-80.
    • (2008) Tumor Biol. , vol.29 , pp. 371-380
    • Molina, R.1    Auge, J.M.2    Bosch, X.3    Escudero, J.M.4    Marrades, R.5    Vĩolas, N.6
  • 25
    • 33846918200 scopus 로고    scopus 로고
    • CEA, CA 19.9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice
    • Duraker N, Hot S, Polat Y, Höbek N, Gençler N, Urhan N. CEA, CA 19.9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. J Surg Oncol. 2007;95:142-7.
    • (2007) J Surg Oncol. , vol.95 , pp. 142-147
    • Duraker, N.1    Hot, S.2    Polat, Y.3    Höbek, N.4    Gençler, N.5    Urhan, N.6
  • 26
    • 84863433967 scopus 로고    scopus 로고
    • Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions
    • Trape J, Molina R, Sant F. Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions. Tumor Biol. 2005;51:219-22.
    • (2005) Tumor Biol. , vol.51 , pp. 219-222
    • Trape, J.1    Molina, R.2    Sant, F.3
  • 27
    • 66449111135 scopus 로고    scopus 로고
    • Usefulness of serum tumor markers, including progastrinreleasing peptide in patients with lung cancer: Correlation with histology
    • Molina R, Auge JM, Bosch X, Escudero JM, Vĩolas N, Marrades R, et al. Usefulness of serum tumor markers, including progastrinreleasing peptide in patients with lung cancer: correlation with histology. Tumor Biol. 2009;30:121-9.
    • (2009) Tumor Biol. , vol.30 , pp. 121-129
    • Molina, R.1    Auge, J.M.2    Bosch, X.3    Escudero, J.M.4    Vĩolas, N.5    Marrades, R.6
  • 28
    • 0026600508 scopus 로고
    • Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant diseases
    • Filella X, Molina R, Jo J, Bedini JL, Joseph J, Ballesta AM. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant diseases. Bull Cancer. 1992;79:271-7.
    • (1992) Bull Cancer. , vol.79 , pp. 271-277
    • Filella, X.1    Molina, R.2    Jo, J.3    Bedini, J.L.4    Joseph, J.5    Ballesta, A.M.6
  • 30
    • 0025992203 scopus 로고
    • Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases
    • Molina R, Filella X, Bruix J, Mengual PJ, Bosch J, Calvet X, et al. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem. 1991;37:1379-83.
    • (1991) Clin Chem. , vol.37 , pp. 1379-1383
    • Molina, R.1    Filella, X.2    Bruix, J.3    Mengual, P.J.4    Bosch, J.5    Calvet, X.6
  • 31
    • 37249086687 scopus 로고    scopus 로고
    • False positive findings for tumors markers after curative gastrectomy for gastric cancer
    • Ohtsuka T, Sato S, Kitajima Y. False positive findings for tumors markers after curative gastrectomy for gastric cancer. Dig Dis Sci. 2008;53:73-9.
    • (2008) Dig Dis Sci. , vol.53 , pp. 73-79
    • Ohtsuka, T.1    Sato, S.2    Kitajima, Y.3
  • 34
    • 10444263784 scopus 로고    scopus 로고
    • Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions
    • Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez- Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest. 2004;126:1757-63.
    • (2004) Chest. , vol.126 , pp. 1757-1763
    • Porcel, J.M.1    Vives, M.2    Esquerda, A.3    Salud, A.4    Perez, B.5    Rodriguez-Panadero, F.6
  • 35
    • 0032727907 scopus 로고    scopus 로고
    • Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
    • Miédougé M, Rouzaud P, Salama G, Pujazon MC, Vincent C, Mauduyl MA, et al. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer. 1999;81:1059-61.
    • (1999) Br J Cancer. , vol.81 , pp. 1059-1061
    • Miédougé, M.1    Rouzaud, P.2    Salama, G.3    Pujazon, M.C.4    Vincent, C.5    Mauduyl, M.A.6
  • 36
    • 49549124785 scopus 로고    scopus 로고
    • Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis
    • El-Rachkidy RG, Young HS, Griffiths CE, Camp RD. Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. J Invest Dermatol. 2008;128:2219-24.
    • (2008) J Invest Dermatol. , vol.128 , pp. 2219-2224
    • El-Rachkidy, R.G.1    Young, H.S.2    Griffiths, C.E.3    Camp, R.D.4
  • 38
    • 0042423723 scopus 로고    scopus 로고
    • AFP-producing gastric carcinoma: Multivariate analysis of prognostic factors in 270 patients
    • Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology. 2003;65:95-101.
    • (2003) Oncology. , vol.65 , pp. 95-101
    • Adachi, Y.1    Tsuchihashi, J.2    Shiraishi, N.3    Yasuda, K.4    Etoh, T.5    Kitano, S.6
  • 39
    • 0141533136 scopus 로고    scopus 로고
    • The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: A prospective clinical study
    • Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142-5.
    • (2003) Gastric Cancer. , vol.6 , pp. 142-145
    • Takahashi, Y.1    Takeuchi, T.2    Sakamoto, J.3    Touge, T.4    Mai, M.5    Ohkura, H.6
  • 40
    • 33748133963 scopus 로고    scopus 로고
    • Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy
    • Yonemori K, Ando M, Shibata T, Katsumata N, Matsumoto K, Yamanaka Y, et al. Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy. J Canc Res Clin Oncol. 2006;132:635-42.
    • (2006) J Canc Res Clin Oncol. , vol.132 , pp. 635-642
    • Yonemori, K.1    Ando, M.2    Shibata, T.3    Katsumata, N.4    Matsumoto, K.5    Yamanaka, Y.6
  • 41
    • 0030446523 scopus 로고    scopus 로고
    • Elevated germ cell markers in carcinoma of uncertain primary site do not predict response to platinum based chemotherapy
    • Currow DC, Findlay M, Cox K, Harnette PR. Elevated germ cell markers in carcinoma of uncertain primary site do not predict response to platinum based chemotherapy. Eur J Cancer. 1996;32:2357-9.
    • (1996) Eur J Cancer. , vol.32 , pp. 2357-2239
    • Currow, D.C.1    Findlay, M.2    Cox, K.3    Harnette, P.R.4
  • 42
    • 0036124183 scopus 로고    scopus 로고
    • Tumormarkers in metastatic disease from cancer of unknown primary origin
    • Milovic M, Popov I, Jelic S. Tumormarkers in metastatic disease from cancer of unknown primary origin. Med Sci Mon. 2002;8:25-30.
    • (2002) Med Sci Mon. , vol.8 , pp. 25-30
    • Milovic, M.1    Popov, I.2    Jelic, S.3
  • 43
    • 1942530860 scopus 로고    scopus 로고
    • Diagnostic strategies for unknown primary cancer
    • Varadhachary GR, Abbruzzesse JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer. 2004;100:1776-85.
    • (2004) Cancer. , vol.100 , pp. 1776-1785
    • Varadhachary, G.R.1    Abbruzzesse, J.L.2    Lenzi, R.3
  • 45
    • 10444240305 scopus 로고    scopus 로고
    • Tumor markers in undiagnosed pleural effusions
    • Light RW. Tumor markers in undiagnosed pleural effusions. Chest. 2004;126:1721-2.
    • (2004) Chest. , vol.126 , pp. 1721-1722
    • Light, R.W.1
  • 46
    • 27144452535 scopus 로고    scopus 로고
    • Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer
    • Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest. 2005;128:2298-303.
    • (2005) Chest. , vol.128 , pp. 2298-2303
    • Lee, J.H.1    Chang, J.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.